I am a
Home I AM A Search Login

Uncategorized

Share this

The role of post-trauma stress symptoms in the development of chronic musculoskeletal pain and disability: a systematic review.

Traumatic injuries are among the leading causes of death and disability in the world across all age groups. This systematic review aimed to (1) describe the role of post-traumatic stress symptoms (PTSS) on the development of chronic pain and/or pain-related disability following musculoskeletal trauma, and (2) report pain and or pain-related disability by injury severity/type.

Learn More >

Anxiety and Depressive Symptoms and Disorders in Children and Adolescents With Migraine: A Systematic Review and Meta-analysis.

Though it is presumed that children and adolescents with migraine are at risk of internalizing symptoms and disorders, high-level summative evidence to support this clinical belief is lacking.

Learn More >

Migraine and Mental Health in Pediatrics.

Learn More >

State-Dependent Inhibition of Voltage-Gated Sodium Channels in Neuroblastoma Neuro-2A Cells by Arachidonic Acid from .

Voltage-gated sodium channels (Na) are closely associated with epilepsy, cardiac and skeletal muscle diseases, and neuropathic pain. Several toxic compounds have been isolated from the marine sponge ; however, toxic substances that modulate Na are yet to be identified. This study aimed to identify Na inhibitors from two snake venoms and using mouse neuroblastoma Neuro-2A cells (N2A), which primarily express the specific Na subtype Na1.7, using whole-cell patch-clamp recordings. We successfully isolated arachidonic acid (AA, ) from the hexane extract of , and then the fatty acid-mediated modulation of Na in N2A was investigated in detail for the first time. Octanoic acid (), palmitic acid (), and oleic acid () showed no inhibitory activity at 100 μM, whereas AA (), dihomo-γ-linolenic acid (DGLA, ), and eicosapentaenoic acid (EPA, ) showed IC values of 6.1 ± 2.0, 58 ± 19, and 25 ± 4.0 μM, respectively ( = 4, mean ± SEM). Structure and activity relationships were investigated for the first time using two ω-3 polyunsaturated fatty acids (PUFAs), EPA () and eicosatetraenoic acid (ETA, ), and two ω-6 PUFAs, AA () and DGLA (), to determine their effects on a resting state, activated state, and inactivated state. Steady-state analysis showed that the half inactivation potential was largely hyperpolarized by 10 μM AA (), while 50 μM DGLA (), 50 μM EPA (), and 10 μM ETA () led to a slight change. The percentages of the resting state block were 24 ± 1, 22 ± 1, 34 ± 4, and 38 ± 9% in the presence of AA (), DGLA (), EPA (), and ETA (), respectively, with EPA () and ETA () exhibiting a greater inhibition than both AA () and DGLA (), and their inhibitions did not increase in the following depolarization pulses. None of the compounds exhibited the use-dependent block. The half recovery times from the inactivated state for the control, AA (), DGLA (), EPA (), and ETA () were 7.67 ± 0.33, 34.3 ± 1.10, 15.5 ± 1.10, 10.7 ± 0.31, and 3.59 ± 0.18 ms, respectively, with AA () exhibiting a distinctively large effect. Overall, distributed binding to the resting and the inactivated states of Na would be significant for the inhibition of Na, which presumably depends on the active structure of each PUFA.

Learn More >

Biomechanical Phenotyping of Chronic Low Back Pain: Protocol for BACPAC.

Biomechanics represents the common final output through which all biopsychosocial constructs of back pain must pass, making it a rich target for phenotyping. To exploit this feature, several sites within the NIH Back Pain Consortium (BACPAC) have developed biomechanics measurement and phenotyping tools. The overall aims of this paper were to: 1) provide a narrative review of biomechanics as a phenotyping tool; 2) describe the diverse array of tools and outcome measures that exist within BACPAC; and 3) highlight how leveraging these technologies with the other data collected within BACPAC may elucidate the relationship between biomechanics and other metrics used to characterize low back pain (LBP).

Learn More >

COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis.

The COVID-19 vaccination in autoimmune diseases (COVAD) study aimed to assess short-term COVID-19 vaccination-related adverse events (AEs) in rheumatoid arthritis (RA) patients.

Learn More >

Deep Learning for Multi-Tissue Segmentation and Fully Automatic Personalized Biomechanical Models from BACPAC Clinical Lumbar Spine MRI.

In vivo retrospective study of fully automatic quantitative imaging feature extraction from clinically acquired lumbar spine magnetic resonance imaging (MRI).

Learn More >

Can internet-delivered pain management programs reduce psychological distress in chronic pain? Exploring relationships between anxiety and depression, pain intensity, and disability.

Adults with chronic pain who also report high pain intensity and disability are more likely to experience depression and anxiety symptoms. The current study examined changes in anxiety and depression symptoms after an internet-delivered pain management program based on baseline pain intensity and disability severity categories. In a secondary analysis of data from four randomised controlled trials (n = 1333), greater pain intensity and disability were associated with increased odds of elevated anxiety or depression symptoms at baseline. Treatment led to greater reductions in anxiety and depression symptoms compared to a waitlist control, and these improvements occurred irrespective of baseline pain intensity or disability severity. Those individuals who reported ≥ 30% improvements in pain intensity or disability at post-treatment were more likely to also report ≥ 30% improvements in psychological symptoms. Importantly, most participants who achieved ≥ 30% improvements in depression and anxiety had not experienced such improvements in pain intensity or disability. These findings suggest that emerging internet-delivered pain management programs can lead to reductions in psychological distress even when pain intensity and disability are severe or do not improve with treatment. This indicates the value of such treatments in treating distress and improving mental health in people with chronic pain.

Learn More >

The diverse functions of the DEG/ENaC family: linking genetic and physiological insights.

The DEG/ENaC family of ion channels was defined based on the sequence similarity between degenerins (DEG) from the nematode Caenorhabditis elegans and subunits of the mammalian epithelial sodium channel (ENaC), and also includes a diverse array of non-voltage-gated cation channels from across animal phyla, including the mammalian acid-sensing ion channels (ASICs) and Drosophila pickpockets. ENaCs and ASICs have wide ranging medical importance, for example, ENaCs play an important role in respiratory and renal function, and ASICs in ischemia and inflammatory pain, as well as being implicated in memory and learning. Electrophysiological approaches, both in vitro and in vivo, have played an essential role in establishing the physiological properties of this diverse family, identifying an array of modulators and implicating them in an extensive range of cellular functions, including mechanosensation, acid sensation and synaptic modulation. Likewise, genetic studies in both invertebrates and vertebrates have played an important role in linking our understanding of channel properties to function at the cellular and whole animal/behavioural level. Drawing together genetic and physiological evidence is essential to furthering our understanding of the precise cellular roles of DEG/ENaC channels, with the diversity among family members allowing comparative physiological studies to dissect the molecular basis of these diverse functions. Abstract figure legend Schematic illustrating the diverse modulators and stimuli that influence DEG/ENaC function (blue arrows) and the diverse range of functions in which they have been implicated (green arrows), in an array of animals, exemplified by those depicted. Created with Biorender.com. This article is protected by copyright. All rights reserved.

Learn More >

Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients.

The identification of predictors of response to antiCGRP mAbs could favor tailored therapies and personalized treatment plans. This study is aimed at investigating predictors of ≥ 50%, ≥ 75% and 100% response at 24 weeks in patients with high-frequency episodic (HFEM: 8-14 days/month) or chronic migraine (CM).

Learn More >

Search